Comparison between Saamya Biotech IPO and Supreme Infrastructure IPO.
Saamya Biotech IPO is a Mainboard Bookbuilding IPO proposed to list at BSE while Supreme Infrastructure IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Saamya Biotech IPO is up to ₹15.01 Cr whereas the issue size of the Supreme Infrastructure IPO is up to ₹37.54 Cr. The final issue price of Saamya Biotech IPO is ₹10.00 per share and of Supreme Infrastructure IPO is ₹108.00 per share.
| Saamya Biotech IPO | Supreme Infrastructure IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹95.00 per share | |
| Issue Price (Upper) | ₹108.00 per share | |
| Issue Price (Final) | ₹10.00 per share | ₹108.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 500 shares | 60 shares |
| Fresh Issue Size | 1,50,12,500 shares | 34,75,812 shares |
| Fresh Issue Size (Amount) | up to ₹15.01 Cr | up to ₹37.54 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 1,50,12,500 shares | 34,75,812 shares |
| Issue Size Total (Amount) | up to ₹15.01 Cr | up to ₹37.54 Cr |
Saamya Biotech IPO opens on Sep 25, 2007, while Supreme Infrastructure IPO opens on Sep 21, 2007. The closing date of Saamya Biotech IPO and Supreme Infrastructure IPO is Sep 28, 2007, and Sep 26, 2007, respectively.
| Saamya Biotech IPO | Supreme Infrastructure IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Sep 25, 2007 | Sep 21, 2007 |
| Issue Close | Sep 28, 2007 | Sep 26, 2007 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Oct 19, 2007 | Oct 18, 2007 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Saamya Biotech IPO P/E ratio is , as compared to Supreme Infrastructure IPO P/E ratio of .
| Saamya Biotech IPO | Supreme Infrastructure IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 100 | 80.1 | ||||
| Promoter Shareholding (Post-Issue) | 35.01 | 60.04 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹23.08 Cr. | ₹149.85 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 32.21 |
In the Saamya Biotech IPO Retail Individual Investors (RII) are offered 67,50,000 shares while in Supreme Infrastructure IPO retail investors are offered 67,50,000 shares. Qualified Institutional Buyers (QIB) are offered 15,00,000 shares in Saamya Biotech IPO and 17,37,500 shares in Supreme Infrastructure IPO.
| Saamya Biotech IPO | Supreme Infrastructure IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | ||
| QIB | 15,00,000 shares | 17,37,500 shares |
| NII | 67,50,000 shares | 5,21,250 shares |
| RII | 67,50,000 shares | 12,16,250 shares |
| Employee | ||
| Others | ||
| Total | 1,50,00,000 shares | 34,75,000 shares |
Saamya Biotech IPO subscribed 16.61x in total, whereas Supreme Infrastructure IPO subscribed 52.75x.
| Saamya Biotech IPO | Supreme Infrastructure IPO | |
|---|---|---|
| QIB (times) | 10.99x | 52.11x |
| NII (times) | 7.36x | 65.43x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 27.12x | 48.23x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 16.61x | 52.75x |
